Technical Analysis for BPTH - Bio-Path Holdings Inc

Grade Last Price % Change Price Change
grade F 10.59 -2.58% -0.28
BPTH closed down 2.58 percent on Thursday, November 14, 2019, on 81 percent of normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Earnings due: Nov 15

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical BPTH trend table...

Date Alert Name Type % Chg
Fell Below 50 DMA Bearish 0.00%
MACD Bearish Centerline Cross Bearish 0.00%
180 Bearish Setup Bearish Swing Setup 0.00%
Stochastic Reached Oversold Weakness 0.00%
Outside Day Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Crossed Above 50 DMA Bullish -2.58%
Fell Below 50 DMA Bearish -2.31%
Stochastic Buy Signal Bullish -2.31%
Inside Day Range Contraction -2.31%

Older signals for BPTH ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Bio-Path Holdings, Inc., a biotechnology company, focuses on developing therapeutic products utilizing its proprietary liposomal delivery technology to systemically distribute nucleic acid drugs throughout the human body with a simple intravenous transfusion. Its lead product candidate, Liposomal Grb-2, is in a Phase I study for blood cancers and in preclinical studies for triple negative and inflammatory breast cancers. The company's other drug candidate, Liposomal Bcl-2, is ready for the clinic where it would be evaluated in lymphoma and solid tumors. Bio-Path Holdings, Inc. was founded in 2007 and is based in Houston, Texas.
Biotechnology Solid Tumors Breast Cancer Cell Biology Lymphoma Therapeutic Products Oncogenes Apoptosis Blood Cancers
Is BPTH a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 73.52
52 Week Low 1.61
Average Volume 57,702
200-Day Moving Average 13.2244
50-Day Moving Average 10.8448
20-Day Moving Average 11.399
10-Day Moving Average 11.018
Average True Range 0.6156
ADX 20.43
+DI 19.5172
-DI 19.3559
Chandelier Exit (Long, 3 ATRs ) 11.4932
Chandelier Exit (Short, 3 ATRs ) 12.2376
Upper Bollinger Band 12.464
Lower Bollinger Band 10.334
Percent B (%b) 0.12
BandWidth 18.68585
MACD Line -0.0201
MACD Signal Line 0.0873
MACD Histogram -0.1074
Fundamentals Value
Market Cap 1.06 Billion
Num Shares 100 Million
EPS -0.07
Price-to-Earnings (P/E) Ratio -151.29
Price-to-Sales 3232.58
Price-to-Book 4.77
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 11.52
Resistance 3 (R3) 11.59 11.34 11.37
Resistance 2 (R2) 11.34 11.11 11.31 11.31
Resistance 1 (R1) 10.97 10.96 10.85 10.90 11.26
Pivot Point 10.72 10.72 10.66 10.69 10.72
Support 1 (S1) 10.35 10.49 10.23 10.28 9.92
Support 2 (S2) 10.10 10.34 10.07 9.87
Support 3 (S3) 9.73 10.10 9.82
Support 4 (S4) 9.66